Sandy Miller PARIS, May 22, 2019 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system. Today at the EuroPCR annual course in Paris, new 6-month data from the CLASP study of the PASCAL … Read more
Read Full Article here: https://www.medtechdive.com/news/abbott-gains-expanded-indication-for-mitraclip-valve-repair-device/550580/
Silicon Valley, December, 2018 – Proportionate and Disproportionate Functional Mitral Regurgitation A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials Paul A. Grayburn, Anna Sannino and Milton Packer Read full article here: http://imaging.onlinejacc.org/content/early/2018/11/28/j.jcmg.2018.11.006
Silicon Valley, September, 2018 – COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF. Physicians responded with shock and excitement to findings, but struggled to reconcile the results with the MITRA-FR trial. Read article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1806640 Gregg W. Stone, M.D. et al. for the COAPT Investigators*
Silicon Valley, August, 2018 – Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation Jean-François Obadia, M.D. et al., for the MITRA-FR Investigators* Read full article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1805374